Menu

rarecancers_logo_tagline_rgb_72dpi

The European Action Against Rare Cancers campaign was launched on 24 June 2009.  ECL is on the organising committee for the campaign, which urges European policy-makers to prioritise better treatment and care for patients with rare cancers within the framework of the new Commission Communication on cancer and other recent policy initiatives such as the Council Recommendation on Rare Diseases.

February 2014:  Consensus was established on how to improve pathologic diagnosis of rare cancers at the 'Rare Cancers Consensus Meeting: Pathology in Rare Cancers', 10–11 February 2014 in Brussels. 

For updates and news, visit the Rare Cancers EU website: http://www.rarecancerseurope.org/

Archive Info:

ECL is one of the supporting organisations. The Call to Action – an international petition appeals to all stakeholders to initiate targeted actions to address the challenges of rare cancers.

Don’t forget to sign the Call to Action Against Rare Cancers!

You may be interested...

Cancer Screening in the EU, 1 June 2017

Cancer Screening in the EU, Thursday 1 June 2017 9:00 - 11:00, European Parliament, room A1E-3
Kindl [ ... ]

+ Full Story
News from the ECL 2017

      April 2017 The European Solidarity Corps The European Solidarity Corps ( [ ... ]

+ Full Story
ECL Annual Meetings Copenhagen, Denmark, September...

 ECL Annual Meetings are open only to ECL member leagues and invited guests   These ECL  [ ... ]

+ Full Story
Other Articles
  
 The Association of European Cancer Leagues implements activities which receive financial support from the European Commission under an Operating Grant from the European Union's Health Programme (2014-2020). The views expressed on our website and reports do not necessarily reflect the official views of the EU institutions.
 
EU flag and co-funded by health programme LOGO  

 

  

 

The text of this webpage is available for modification and reuse under the terms of the Creative Commons Attribution-Sharealike 3.0 Unported License and the GNU Free Documentation License (unversioned, with no invariant sections, front-cover texts, or back-cover texts).

 

 
Go to top